BioSpace News Archive

Celularity Inc. announced financial results for the first quarter ended March 31, 2022, and provided a corporate update.

INVO Bioscience, Inc. announced it has entered an exclusive distribution agreement with Onesky Holdings Limited for Mainland China.

PolarityTE, Inc. announced that the Company will effectuate a 1-for-25 reverse stock split of the Company’s issued and outstanding common stock, which will be effective under Delaware law at 4:15 p.m. Eastern Time on Monday, May 16, 2022.

Scholar Rock, a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, provided a business update and reported financial results for the first quarter ended March 31, 2022.

Abbott has agreed to enter into a consent decree with the U.S. Food and Drug Administration related to its Sturgis, Mich., infant formula plant.

Biora Therapeutics, Inc. announced that the Company’s management team will be presenting a corporate overview and participating in one-on-one meetings, upon request, with conference attendees at the upcoming H.C. Wainwright Global Investment Conference, which is taking place both virtually and in-person at the Fontainebleau Hotel in Miami, Florida, May 23 to 26, 2022.

SanaraMedTech Inc., a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced its strategic, operational and financial results for the quarter ended March 31, 2022.

Adamis Pharmaceuticals Corporation, a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, announced financial results for the quarter ending March 31, 2022.

There is a new and convenient way for millions of individuals to assess whether they are at risk for developing diabetes.

Ortho Clinical Diagnostics Holdings plc announced that based on a preliminary vote count by its proxy solicitor, Ortho shareholders have voted to approve the combination of the Company with Quidel Corporation pursuant to the Business Combination Agreement, dated December 22, 2021, by and among the Company, Quidel, and the other parties thereto.